Please assess the completion status of the following clinical trial:

Trial Title: Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic osseous bone lesion(s) from any malignancy, whether primary of metastatic, with histological confirmation of malignancy.~* Currently enrolled in hospice and referred for single fraction palliative radiotherapy.~* Performance status (to be evaluated by the radiation oncologist), Karnofsky Performance Scale ≥ 20 or ECOG Performance Scale \< 5 .~* Ability to understand and willingness to sign a written informed consent document~Exclusion Criteria:~* Pregnancy.~* Unable to understand English.~* Unable to complete forms with assistance.~* Concurrent enrollment in a study of pain management involving medications or devices.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (radiation therapy) (Type: EXPERIMENTAL): This is a survey study to evaluate the feasibility and effectiveness of an affordable, $400 flat rate, same-day consultation, simulation, and delivery of a single fraction of palliative radiation therapy for patients with symptomatic bony metastatic disease who are currently enrolled in hospice. Treatment planning and delivery of palliative radiotherapy will utilize standard of care techniques. A physician survey of feasibility will be conducted on the treatment day. Patient surveys will conducted on the day of treatment and at 2 weeks, 4 weeks, 2 months, 3 months, 4 months, 5 months, and 6 months after treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).